Cultivated-meat company Omeat, which launched earlier this year, has completed construction of its state-of-the-art pilot plant outside Los Angeles, according to a company release. The milestone represents a crucial step toward future production and commercialization of Omeat’s products.
The 15,000-square-foot facility can house bioreactors up to 10,000 liters in size and produce up to 400 tons of product annually, filling an important piece of Omeat’s vertically integrated puzzle. It will provide essential data and insights for scale up of production while ensuring Omeat’s quality, taste and safety standards. It is expected to help Omeat demonstrate its process at scale and clear a path for regulatory review and approval.
Jim Miller, Omeat chief technology officer said in the release: “Omeat’s process begins at our farm with the collection of plasma from Omeat’s herd of Holstein cows. The plasma is transported to the new pilot facility, where it’s used to derive Plenty, Omeat’s affordable and effective proprietary growth factor that replaces the need for Fetal Bovine Serum (FBS). Inside Omeat’s bioreactors, Plenty and bovine cells are combined to produce Omeat ground beef.”